Foundation Resource Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Buy
165,854
+10,014
+6% +$584K 1.13% 34
2025
Q4
$8.41M Buy
155,840
+1,805
+1% +$86.8K 1.12% 29
2025
Q3
$6.95M Buy
154,035
+1,021
+0.7% +$47.7K 1% 33
2025
Q2
$7.08M Buy
153,014
+79
+0.1% +$3.88K 1.1% 33
2025
Q1
$9.33M Sell
152,935
-3,584
-2% -$209K 1.47% 24
2024
Q4
$8.85M Sell
156,519
-773
-0.5% -$43.2K 1.48% 24
2024
Q3
$8.14M Buy
157,292
+93
+0.1% +$4.36K 1.26% 29
2024
Q2
$6.53M Buy
+157,199
New +$7.03M 1.04% 32
2014
Q1
Sell
-5,670
Closed -$301K 69
2013
Q4
$301K Buy
+5,670
New +$289K 0.04% 65

Other funds holding BMY

Foundation Resource Management's BMY Position: Q1 2026 in Review

Foundation Resource Management increased its Bristol-Myers Squibb (BMY) stake by 6.4% in Q1 2026, buying an estimated $584K and bringing the position to 165,854 shares worth $10.1M. The position accounts for 1.13% of the portfolio, ranked #34.

Foundation Resource Management first reported a position in BMY in Q4 2013 and has held it in 9 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Foundation Resource Management held 165,854 shares of Bristol-Myers Squibb worth $10.1M as of Q1 2026.
  • Foundation Resource Management bought 10,014 Bristol-Myers Squibb shares in Q1 2026, an estimated $584K.
  • Bristol-Myers Squibb made up 1.13% of Foundation Resource Management's portfolio in Q1 2026, its #34 holding.
  • Foundation Resource Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 9 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Foundation Resource Management's 13F filing for Q1 2026, filed 21 Apr 2026.